Opening book details…
About this Medicine article
A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease by Ruether, E.; Husmann, R.; Kinzler, E.; Diabl, E.; Klingler, D.; Spatt, J.; Ritter, R.; Schmidt, R.; Taneri, Z.; Winterer, W.; Koper, D.; Kasper, S.; Rainer, M.; Moessler, H. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Ruether, E.; Husmann, R.; Kinzler, E.; Diabl, E.; Klingler, D.; Spatt, J.; Ritter, R.; Schmidt, R.; Taneri, Z.; Winterer, W.; Koper, D.; Kasper, S.; Rainer, M.; Moessler, H.
- Publisher
- Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0268-1315)
- Published
- 2001
- Language
- EN
- ISBN
- 9780000485021
- Field
- Medicine (Health Sciences)